Cargando…
Epigenetic therapy with hydralazine and valproate associated to cisplatin chemoradiation in FIGO stage IIIB. A phase II study
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1796572/ http://dx.doi.org/10.1186/1471-2407-7-S1-A28 |
| _version_ | 1782132232818786304 |
|---|---|
| author | Candelaria, Myrna Cetina, Lucely Garcia, Alicia Wegman-Ostrosky, Talia Robles, Elizabeth González-Fierro, Aurora López-Graniel, Carlos González, Aaron Cantú, David Ribera, Lesbia Taja-Chayeb, Lucia Trejo-Becerril, Catalina Pérez-Cárdenas, Enrique Pérez-Plasencia, Carlos Chavez-Blanco, Alma Dueñas-González, Alfonso |
| author_facet | Candelaria, Myrna Cetina, Lucely Garcia, Alicia Wegman-Ostrosky, Talia Robles, Elizabeth González-Fierro, Aurora López-Graniel, Carlos González, Aaron Cantú, David Ribera, Lesbia Taja-Chayeb, Lucia Trejo-Becerril, Catalina Pérez-Cárdenas, Enrique Pérez-Plasencia, Carlos Chavez-Blanco, Alma Dueñas-González, Alfonso |
| author_sort | Candelaria, Myrna |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-1796572 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2007 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-17965722007-02-09 Epigenetic therapy with hydralazine and valproate associated to cisplatin chemoradiation in FIGO stage IIIB. A phase II study Candelaria, Myrna Cetina, Lucely Garcia, Alicia Wegman-Ostrosky, Talia Robles, Elizabeth González-Fierro, Aurora López-Graniel, Carlos González, Aaron Cantú, David Ribera, Lesbia Taja-Chayeb, Lucia Trejo-Becerril, Catalina Pérez-Cárdenas, Enrique Pérez-Plasencia, Carlos Chavez-Blanco, Alma Dueñas-González, Alfonso BMC Cancer Meeting Abstract BioMed Central 2007-02-05 /pmc/articles/PMC1796572/ http://dx.doi.org/10.1186/1471-2407-7-S1-A28 Text en Copyright © 2007 Candelaria et al; licensee BioMed Central Ltd. |
| spellingShingle | Meeting Abstract Candelaria, Myrna Cetina, Lucely Garcia, Alicia Wegman-Ostrosky, Talia Robles, Elizabeth González-Fierro, Aurora López-Graniel, Carlos González, Aaron Cantú, David Ribera, Lesbia Taja-Chayeb, Lucia Trejo-Becerril, Catalina Pérez-Cárdenas, Enrique Pérez-Plasencia, Carlos Chavez-Blanco, Alma Dueñas-González, Alfonso Epigenetic therapy with hydralazine and valproate associated to cisplatin chemoradiation in FIGO stage IIIB. A phase II study |
| title | Epigenetic therapy with hydralazine and valproate associated to cisplatin chemoradiation in FIGO stage IIIB. A phase II study |
| title_full | Epigenetic therapy with hydralazine and valproate associated to cisplatin chemoradiation in FIGO stage IIIB. A phase II study |
| title_fullStr | Epigenetic therapy with hydralazine and valproate associated to cisplatin chemoradiation in FIGO stage IIIB. A phase II study |
| title_full_unstemmed | Epigenetic therapy with hydralazine and valproate associated to cisplatin chemoradiation in FIGO stage IIIB. A phase II study |
| title_short | Epigenetic therapy with hydralazine and valproate associated to cisplatin chemoradiation in FIGO stage IIIB. A phase II study |
| title_sort | epigenetic therapy with hydralazine and valproate associated to cisplatin chemoradiation in figo stage iiib. a phase ii study |
| topic | Meeting Abstract |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1796572/ http://dx.doi.org/10.1186/1471-2407-7-S1-A28 |
| work_keys_str_mv | AT candelariamyrna epigenetictherapywithhydralazineandvalproateassociatedtocisplatinchemoradiationinfigostageiiibaphaseiistudy AT cetinalucely epigenetictherapywithhydralazineandvalproateassociatedtocisplatinchemoradiationinfigostageiiibaphaseiistudy AT garciaalicia epigenetictherapywithhydralazineandvalproateassociatedtocisplatinchemoradiationinfigostageiiibaphaseiistudy AT wegmanostroskytalia epigenetictherapywithhydralazineandvalproateassociatedtocisplatinchemoradiationinfigostageiiibaphaseiistudy AT robleselizabeth epigenetictherapywithhydralazineandvalproateassociatedtocisplatinchemoradiationinfigostageiiibaphaseiistudy AT gonzalezfierroaurora epigenetictherapywithhydralazineandvalproateassociatedtocisplatinchemoradiationinfigostageiiibaphaseiistudy AT lopezgranielcarlos epigenetictherapywithhydralazineandvalproateassociatedtocisplatinchemoradiationinfigostageiiibaphaseiistudy AT gonzalezaaron epigenetictherapywithhydralazineandvalproateassociatedtocisplatinchemoradiationinfigostageiiibaphaseiistudy AT cantudavid epigenetictherapywithhydralazineandvalproateassociatedtocisplatinchemoradiationinfigostageiiibaphaseiistudy AT riberalesbia epigenetictherapywithhydralazineandvalproateassociatedtocisplatinchemoradiationinfigostageiiibaphaseiistudy AT tajachayeblucia epigenetictherapywithhydralazineandvalproateassociatedtocisplatinchemoradiationinfigostageiiibaphaseiistudy AT trejobecerrilcatalina epigenetictherapywithhydralazineandvalproateassociatedtocisplatinchemoradiationinfigostageiiibaphaseiistudy AT perezcardenasenrique epigenetictherapywithhydralazineandvalproateassociatedtocisplatinchemoradiationinfigostageiiibaphaseiistudy AT perezplasenciacarlos epigenetictherapywithhydralazineandvalproateassociatedtocisplatinchemoradiationinfigostageiiibaphaseiistudy AT chavezblancoalma epigenetictherapywithhydralazineandvalproateassociatedtocisplatinchemoradiationinfigostageiiibaphaseiistudy AT duenasgonzalezalfonso epigenetictherapywithhydralazineandvalproateassociatedtocisplatinchemoradiationinfigostageiiibaphaseiistudy |